Financials Novoray Corporation

Equities

688300

CNE100003PN0

Commodity Chemicals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-19 pm EDT 5-day change 1st Jan Change
49 CNY -0.99% Intraday chart for Novoray Corporation +7.36% -7.46%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,907 4,026 9,532 6,069 9,835 9,102 - -
Enterprise Value (EV) 1 3,907 4,026 9,532 6,069 9,835 9,102 9,102 9,102
P/E ratio 52.3 x 36.3 x 55.2 x 32.2 x 56.3 x 41.5 x 31.4 x 26.4 x
Yield 1.1% 1.07% 0.55% - 0.94% 0.67% 0.92% 0.96%
Capitalization / Revenue 12.4 x 9.96 x 15.3 x 9.17 x 13.8 x 10.4 x 8.33 x 7.12 x
EV / Revenue 12.4 x 9.96 x 15.3 x 9.17 x 13.8 x 10.4 x 8.33 x 7.12 x
EV / EBITDA - 28.7 x 43.3 x - 40.1 x 27.8 x 22.8 x 18.2 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 4.36 x 4.18 x 8.72 x 4.93 x 7.3 x 6.11 x 5.14 x 4.63 x
Nbr of stocks (in thousands) 185,746 185,746 185,746 185,746 185,746 185,746 - -
Reference price 2 21.04 21.68 51.32 32.67 52.95 49.00 49.00 49.00
Announcement Date 2/27/20 2/23/21 2/27/22 2/27/23 2/22/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 315.3 404.2 624.7 662 711.7 875.3 1,092 1,278
EBITDA 1 - 140.2 220.2 - 245 327 400 501
EBIT 1 85.13 123.9 197.2 190.2 195.4 248.8 318.4 384
Operating Margin 27% 30.65% 31.57% 28.73% 27.45% 28.42% 29.15% 30.04%
Earnings before Tax (EBT) 1 86.83 128.4 197.4 193.2 197.4 251.5 321 387
Net income 1 74.69 110.9 172.9 188.2 174 219 289.4 344.3
Net margin 23.69% 27.44% 27.67% 28.44% 24.45% 25.02% 26.49% 26.94%
EPS 2 0.4022 0.5971 0.9303 1.013 0.9400 1.180 1.560 1.853
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.2314 0.2314 0.2814 - 0.5000 0.3300 0.4500 0.4700
Announcement Date 2/27/20 2/23/21 2/27/22 2/27/23 2/22/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 19.2% 12% 16.9% 16.3% 13.6% 14.8% 16.5% 17.5%
ROA (Net income/ Total Assets) - 10.5% 14.4% - 13.5% 11.8% 13.1% 13.9%
Assets 1 - 1,058 1,199 - 1,289 1,850 2,216 2,474
Book Value Per Share 2 4.820 5.190 5.890 6.620 7.250 8.020 9.540 10.60
Cash Flow per Share 2 0.4300 0.4800 0.8300 1.300 1.330 1.000 1.440 1.760
Capex 1 60.3 124 208 155 52.9 124 139 115
Capex / Sales 19.14% 30.7% 33.27% 23.39% 7.44% 14.17% 12.68% 9%
Announcement Date 2/27/20 2/23/21 2/27/22 2/27/23 2/22/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
49 CNY
Average target price
53 CNY
Spread / Average Target
+8.16%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688300 Stock
  4. Financials Novoray Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW